Search Results - paul+krogstad

3 Results

Sort By:

2015-829 Novel Antiviral Compounds

Novel Antiviral Compounds to Treat Enterovirus InfectionsSUMMARYResearchers in UCLA Department of Molecular & Medical Pharmacology have used a rapid, live virus assay to develop potent enterovirus inhibitors.BACKGROUNDHuman enteroviruses (EVs) are a genus of more than 110 serologically distinct, small, non-enveloped RNA viruses responsible for poliomyelitis...

Published: 9/14/2023 | Inventor(s): Paul Krogstad, Michael Jung, Jun Zuo, Yanpeng Xing

Keywords(s): Infectious Diseases, Therapeutics & Vaccines

Category(s): Therapeutics, Therapeutics > Infectious Diseases

2017-99J A PROGNOSTIC BIOMARKER FOR COCCIDIOIDOMYCOSIS

A Prognostic Biomarker For CoccidioidomycosisSUMMARYUCLA researchers in the Department of Pediatrics and the Department of Molecular and Medical Pharmacology have identified a prognostic biomarker for Coccidioidomycosis.BACKGROUNDCoccidioidomycosis, also known as valley fever, is an infection caused by the fungus Coccidioides. Infection of coccidioidomycosis...

Published: 7/19/2023 | Inventor(s): Paul Krogstad

Keywords(s): Diagnostic Markers & Platforms, Infectious Diseases

Category(s): Diagnostic Markers, Therapeutics > Infectious Diseases

2016-99I Novel Inhibitor of HIV-1 Replication

Novel Inhibitor of HIV ReplicationSUMMARYUCLA researchers in the David Geffen School of Medicine have discovered a new small molecule inhibitor for HIV-1 replication.BACKGROUNDVirus-borne diseases represent a significant proportion of infectious diseases worldwide. These diseases, including HIV the virus that causes AIDS which affect millions of people,...

Published: 7/19/2023 | Inventor(s): Paul Krogstad, Jun Zuo

Keywords(s): Infectious Diseases, Therapeutics & Vaccines

Category(s): Therapeutics, Therapeutics > Infectious Diseases